Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - Other
Ratios

Vistagen Therapeutics (VTGN) Long-Term Debt Issuances (2020 - 2025)

Vistagen Therapeutics (VTGN) has disclosed Long-Term Debt Issuances for 5 consecutive years, with $1.0 million as the latest value for Q2 2025.

  • Quarterly Long-Term Debt Issuances changed N/A to $1.0 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $224400.0 for FY2021, N/A changed from the prior year.
  • Long-Term Debt Issuances hit $1.0 million in Q2 2025 for Vistagen Therapeutics, up from $224400.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $1.0 million in Q2 2025 to a low of $1.0 million in Q2 2025.